(Q35208840)

7 August 2017

1 reference

title

Molecular markers in clinical radiation oncology (English)

1 reference

7 August 2017

Bruce G Haffty

1

1 reference

PubMed ID

12947398

7 August 2017

Peter M Glazer

series ordinal

2

1 reference

PubMed ID

12947398

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

22

1 reference

7 August 2017

5915-5925

1 reference

7 August 2017

37

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206704

7 August 2017

0 references

cites work

p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Molecular prognostic factors for breast cancer metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Farnesyltransferase inhibitors as radiation sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Predicting radioresistance in early glottic squamous cell carcinoma by DNA content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Regulation of p53 expression by the RAS-MAP kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Thymocyte apoptosis induced by p53-dependent and independent pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Mismatch correction at O 6 -methylguanine residues in E. coli DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Biologic factors and response to radiotherapy in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

The predictive value of HER2 in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

The cellular response to p53: the decision between life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Biologic Approaches to Managing Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Radiosensitization mediated by a transfected anti-erbB-2 single-chain antibody in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Mutation of p53 in squamous cell cancer of the head and neck: relationship to tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Prognostic factors in head and neck cancer: histologic grading, DNA ploidy, and nodal status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206704

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206704

1 reference

7 August 2017

1 reference

PubMed ID

12947398